Malaria image

Sanaria’s malaria vaccine shows promise

August 9, 2013
Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria

Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …

NICE image

AllTrials campaign releases manifesto

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency

The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …

Ranbaxy image

Ranbaxy taps into Malaysian growth with second facility

August 9, 2013
Manufacturing and Production ASEAN, Ranbaxy, asian, malaysian

Indian drugmaker Ranbaxy has signed a deal to construct a new $35 million manufacturing facility in Malaysia that will triple …

GSK banks on bioelectronics with new fund

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …

glen_campbell_bmj

BMJ appoints US managing director

August 9, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMJ, Campbell

Medical journal BMJ has hired Glen Campbell from Elsevier to be its US managing director. Campbell joins BMJ on 2 …

Votrient image

GSK seeks licence extensions

August 8, 2013
Sales and Marketing Cervarix, EMA, GSK, Votrient

GlaxoSmithKline is seeking to extend the licences of two of its brands, Cervarix and Votrient, in a bid to extend …

Novartis image

Novartis recognised for efforts in cancer

August 8, 2013
Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis

Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …

Afinitor image

Late-stage failure for Afinitor

August 8, 2013
Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …

New junior planner at PAN

August 8, 2013
Medical Communications, Sales and Marketing Pan, comms, doshi

Parrus Doshi has joined creative comms agency PAN from Langland Advertising as junior planner. Doshi was an account manager at …

Merck image

Merck to shut New Jersey campus, shedding 113 jobs

August 8, 2013
Manufacturing and Production Jobs, Merck, Schering-Plough, cuts

Merck & Co has followed through with an earlier threat to close down its manufacturing operations at Kenilworth, New Jersey. …

Erbitux image

Merck KGaA declines in Q2

August 7, 2013
Sales and Marketing Erbitux, Merck KGaA, Q2, Serono

Sales of cancer drug Erbitux dropped as Merck Serono’s revenues for the second quarter of 2013 dipped year-on-year, the firm …

NHS image

Report: ‘Improve NHS safety’

August 7, 2013
Sales and Marketing Cameron, Hunt, Mid Staffs, NHS

Patient safety is the key to future NHS success, according to a new review commissioned after the final report of …

Eylea image

Eylea trial boost in DME

August 7, 2013
Research and Development, Sales and Marketing Bayer, DME, Eylea, regenenron

The rival treatment to Novartis’ Lucentis has posted encouraging new study results in patients with diabetic macular oedema (DME). In …

ICH starts consultation on elemental impurities guidance

August 7, 2013
Manufacturing and Production ICH, Q3D, Taylor, USP

The International Conference on Harmonization (ICH) has started the consultation period on its long-awaited guidance on elemental impurities, a couple …

matt_foster

Waggener Edstrom expands UK healthcare team

August 7, 2013
Medical Communications, Research and Development, Sales and Marketing Waggener Edstrom, foster

Comms agency Waggener Edstrom Worldwide (WE) has appointed Matt Foster to its healthcare practice as an account director. Foster will …

GSK image

FDA makes GSK wait

August 6, 2013
Sales and Marketing FDA, GSK, albiglutide, diabetes

The FDA is making GlaxoSmithKline wait for a verdict on the manufacturer’s investigational type 2 diabetes treatment albiglutide, extending its …

Tyverb image

GSK loses Tyverb patent

August 6, 2013
Sales and Marketing Cancer, GSK, GlaxoSmithKline, Tyverb

GlaxoSmithKline has received a knockback from authorities in India, who have revoked the patent on its breast cancer drug Tyverb. …

Perjeta image

Roche breast cancer drug Perjeta rejected by NICE

August 6, 2013
Sales and Marketing Cancer, NICE, Perjeta, Roche

NICE is not recommending Roche’s next generation breast cancer drug Perjeta as a treatment for a particular type of advanced …

The Gateway to Local Adoption Series

Latest content